Literature DB >> 27401947

The clinical symptoms of Parkinson's disease.

Sigurlaug Sveinbjornsdottir1,2.   

Abstract

In this review, the clinical features of Parkinson's disease, both motor and non-motor, are described in the context of the progression of the disease. Also briefly discussed are the major treatment strategies and their complications. Parkinson's disease is a slowly progressing neurodegenerative disorder, causing impaired motor function with slow movements, tremor and gait and balance disturbances. A variety of non-motor symptoms are common in Parkinson's disease. They include disturbed autonomic function with orthostatic hypotension, constipation and urinary disturbances, a variety of sleep disorders and a spectrum of neuropsychiatric symptoms. This article describes the different clinical symptoms that may occur and the clinical course of the disease. This article is part of a special issue on Parkinson disease.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  Parkinson's disease; clinical symptoms; dopamine; therapy

Mesh:

Year:  2016        PMID: 27401947     DOI: 10.1111/jnc.13691

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  175 in total

Review 1.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

Review 2.  Impact of membrane curvature on amyloid aggregation.

Authors:  Mayu S Terakawa; Yuxi Lin; Misaki Kinoshita; Shingo Kanemura; Dai Itoh; Toshihiko Sugiki; Masaki Okumura; Ayyalusamy Ramamoorthy; Young-Ho Lee
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-28       Impact factor: 3.747

3.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

4.  Treadmill Exercise Prevents Increase of Neuroinflammation Markers Involved in the Dopaminergic Damage of the 6-OHDA Parkinson's Disease Model.

Authors:  Caroline Cristiano Real; Priscila Crespo Garcia; Luiz R G Britto
Journal:  J Mol Neurosci       Date:  2017-08-11       Impact factor: 3.444

5.  A minimally invasive neurostimulation method for controlling abnormal synchronisation in the neuronal activity.

Authors:  Malbor Asllani; Paul Expert; Timoteo Carletti
Journal:  PLoS Comput Biol       Date:  2018-07-19       Impact factor: 4.475

6.  Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.

Authors:  Xinrong Liu; Shuya Liu; Yong Tang; Zhengjia Pu; Hong Xiao; Jieying Gao; Qi Yin; Yan Jia; Qunhua Bai
Journal:  Neurochem Res       Date:  2021-03-15       Impact factor: 3.996

7.  The relationship between Parkinson's disease symptoms and caregiver quality of life.

Authors:  Richard S Henry; Sarah K Lageman; Paul B Perrin
Journal:  Rehabil Psychol       Date:  2020-02-17

Review 8.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

Review 9.  Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.

Authors:  Kevin M Budge; Matthew L Neal; Jason R Richardson; Fayez F Safadi
Journal:  Mol Neurobiol       Date:  2017-08-30       Impact factor: 5.590

10.  The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.

Authors:  Nida Jamali-Raeufy; Zahra Mojarrab; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Javad Fahanik-Babaei; Mina Goudarzi
Journal:  Metab Brain Dis       Date:  2020-02-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.